Skip to main content

Janssen Pharmaceuticals Develops Facility in Ireland

Published 3/24/2003

Janssen Pharmaceuticals has selected a subsidiary of Pasadena-based Jacobs Engineering Group to provide engineering services for a new active pharmaceutical ingredients (API) manufacturing plant at Janssen's existing Little Island site in Ireland. The facility will expand manufacturing operations for existing products and will produce one new aseptic API product. Janssen, based in Titusville, N.J., is a subsidiary of Johnson & Johnson.